Clinical Trial Update: An Open Label, Phase 1b, Ascending Dose Study of DM199 [Phase 1]

View source ↗

Summary

DiaMedica Therapeutics announced the completion of an open-label, Phase 1b ascending-dose study of DM199 in stroke. The trial aimed to assess safety and pharmac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• DM199

Snippet

Sponsor: DiaMedica Therapeutics Inc | Conditions: Stroke | Phase 1 | Status: COMPLETED